Positive relationship between subsequent chemotherapy and overall survival in pancreatic cancer: Meta-analysis of postprogression survival for first-line chemotherapy

被引：0
|
作者：
Kasuga, Akiyoshi [1 ]
Hamamoto, Yasuo [1 ]
Takeuchi, Ayano [2 ]
Kawasaki, Kenta [1 ]
Suzuki, Takeshi [1 ]
Hirata, Kenro [1 ]
Sukawa, Yasutaka [1 ]
Takaishi, Hiromasa [1 ]
Kanai, Takanori [1 ]
机构：
[1] Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo, Japan
[2] Keio Univ, Sch Med, Dept Prevent Med & Publ Hlth, Tokyo, Japan
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2016年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1718
引用
收藏
页码：257 / 257
页数：1
相关论文
共 50 条
  • [41] Effectiveness and safety of adjuvant chemotherapy compared to neoadjuvant chemotherapy in patients with penile cancer and positive lymph nodes regarding overall survival and free disease survival: a systematic review and meta-analysis
    Paz Rojas, Juan Fernando
    Ballestas Almario, Carlos A.
    Andres Garcia-Perdomo, Herney
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (05) : 200.e11 - 200.e18
  • [42] Immune checkpoint inhibitors and chemotherapy in first-line NSCLC: a meta-analysis
    Petrelli, Fausto
    Ferrara, Roberto
    Signorelli, Diego
    Ghidini, Antonio
    Proto, Claudia
    Roudi, Raheleh
    Sabet, Mehrdad N.
    Facelli, Sara
    Garassino, Marina C.
    Luciani, Andrea
    Roviello, Giandomenico
    IMMUNOTHERAPY, 2021, 13 (07) : 621 - 632
  • [43] Prolonged survival with first-line chemotherapy in advanced extrahepatic cholangiocarcinoma
    Chrystle, Mascarenhas
    Sanyo, D'souza
    BMJ CASE REPORTS, 2023, 16 (03)
  • [44] Standard chemotherapy is superior to high-dose chemotherapy with autologous stem cell transplantation on overall survival as the first-line therapy for patients with aggressive non-Hodgkin lymphoma: a meta-analysis
    Jing Wang
    Ping Zhan
    Jian Ouyang
    Bing Chen
    Rongfu Zhou
    Yonggong Yang
    Medical Oncology, 2011, 28 : 822 - 828
  • [45] Standard chemotherapy is superior to high-dose chemotherapy with autologous stem cell transplantation on overall survival as the first-line therapy for patients with aggressive non-Hodgkin lymphoma: a meta-analysis
    Wang, Jing
    Zhan, Ping
    Ouyang, Jian
    Chen, Bing
    Zhou, Rongfu
    Yang, Yonggong
    MEDICAL ONCOLOGY, 2011, 28 (03) : 822 - 828
  • [46] Relationship between 6-and 9-month progression-free survival and overall survival in patients with metastatic urothelial cancer treated with first-line cisplatin-based chemotherapy
    Galsky, Matthew D.
    Krege, Susan
    Lin, Chia-Chi
    Hahn, Noah
    Ecke, Thorsten
    Moshier, Erin
    Sonpavde, Guru
    Godbold, James
    Oh, William K.
    Bamias, Aristotle
    CANCER, 2013, 119 (16) : 3020 - 3026
  • [47] Addition of bevacizumab to first-line chemotherapy in advanced colorectal cancer: a systematic review and meta-analysis, with emphasis on chemotherapy subgroups
    Ligia Traldi Macedo
    Andre Bacellar da Costa Lima
    Andre Deeke Sasse
    BMC Cancer, 12
  • [48] Addition of bevacizumab to first-line chemotherapy in advanced colorectal cancer: a systematic review and meta-analysis, with emphasis on chemotherapy subgroups
    Macedo, Ligia Traldi
    da Costa Lima, Andre Bacellar
    Sasse, Andre Deeke
    BMC CANCER, 2012, 12
  • [49] Correlations of survival with progression-free survival, response rate, and disease control rate in advanced biliary tract cancer: a meta-analysis of randomised trials of first-line chemotherapy
    Toshikazu Moriwaki
    Yoshiyuki Yamamoto
    Masahiko Gosho
    Mariko Kobayashi
    Akinori Sugaya
    Takeshi Yamada
    Shinji Endo
    Ichinosuke Hyodo
    British Journal of Cancer, 2016, 114 : 881 - 888
  • [50] Correlations of survival with progression-free survival, response rate, and disease control rate in advanced biliary tract cancer: a meta-analysis of randomised trials of first-line chemotherapy
    Moriwaki, Toshikazu
    Yamamoto, Yoshiyuki
    Gosho, Masahiko
    Kobayashi, Mariko
    Sugaya, Akinori
    Yamada, Takeshi
    Endo, Shinji
    Hyodo, Ichinosuke
    BRITISH JOURNAL OF CANCER, 2016, 114 (08) : 881 - 888
12345